Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis.
Journal: Blood advances
Published: December 05, 2022
Disseminated toxoplasmosis and haemophagocytic lymphohistiocytosis following chimeric antigen receptor T-cell therapy.
Journal: British journal of haematology
Published: January 21, 2020
Decrease in vancomycin-resistant Enterococcus colonization associated with a reduction in carbapenem use as empiric therapy for febrile neutropenia in patients with acute leukemia.
Journal: Infection control and hospital epidemiology
Published: May 03, 2019
Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials.
Journal: Cancer
Published: December 01, 2016
Transcriptome Profiling of Pediatric Core Binding Factor AML.
Journal: PloS one
Published: June 15, 2015
Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 26, 2015
Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 27, 2014
NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report.
Journal: Blood
Published: August 23, 2014
Outpatient bendamustine and idarubicin for upfront therapy of elderly acute myeloid leukaemia/myelodysplastic syndrome: a phase I/II study using an innovative statistical design.
Journal: British journal of haematology
Published: January 21, 2014
The role of quizartinib in the treatment of acute myeloid leukemia.
Journal: Expert opinion on investigational drugs
Published: September 28, 2013
A model for prediction of FLT3-ITD and NPM1 (without FLT3-ITD) positivity in patients with newly diagnosed acute myeloid leukaemia.
Journal: British journal of haematology
Published: July 09, 2013
Last Updated: 09/26/2026